EN
抗体药类似物
Research Grade Levilimab
All
TD-HY583036_1.jpg
TD-HY583036_2.jpg
  • CatalogTD-HY583036
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsBCD-089,CAS:2035008-70-7
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Levilimab


Catalog No. TD-HY583036
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target sIL6R, Interleukin-6 receptor subunit alpha, CD126, IL-6R 1, IL-6R subunit alpha, Membrane glycoprotein 80, gp80, IL6R, IL-6RA, IL-6 receptor subunit alpha, IL-6R-alpha
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P08887
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names BCD-089,CAS:2035008-70-7
Background Levilimab (BCD-089) is a fully humanized anti-interleukin-6 receptor (IL-6R) monoclonal antibody. Levilimab is an inflammation-alleviating antibody. Levilimab can be used for the research of rheumatoid.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HY583036_1.jpg
Bioactivity
 
Detects Human CD126/IL6R/IL-6RA in indirect ELISAs.
TD-HY583036_2.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Levilimab.